Previous works have examined the role of FGFR3 mutations in murine models of bladder cancer and, with the exception of a recent report (19), have consistently demonstrated that FGFR3 mutations alone are not sufficient to promote urothelial tumorigenesis. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.